on 22 Apr 2022
Last Applicant/ Owned by
F-91940 LES ULIS
FR
Serial Number
79159512 filed on 19th Nov 2014
Registration Number
4824458 registered on 06th Oct 2015
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin; injectable pharmaceutical preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin FIBRI FARead More
Pharmaceutical products and preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin; injectable pharmaceutical preparations for use in the treatment of inherited and acquired fibrinogen deficit, namely, blood proteins of natural or transgenic, synthetic or semi-synthetic origin
No 79159512
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 14th Mar 2023 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 15th Feb 2023 | GENERIC MADRID TRANSACTION CREATED |
| 15th Feb 2023 | GENERIC MADRID TRANSACTION SENT TO IB |
| 22nd Dec 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 07th Sep 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 07th Sep 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 22nd Apr 2022 | CANCELLED SECTION 71 |
| 12th Apr 2021 | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| 09th Apr 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 03rd Apr 2021 | CORRECTION TRANSACTION RECEIVED FROM IB |
